ArticleInternational journal of hematology2026
Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan.
Kazuaki Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.